Ocuterra Therapeutics

Developer of eye drop to treat diabetic eye disease

placeBoston, Massachusetts, United States calendar_todayFounded 2020 groups4 employees language ocuterratx.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 915 times.

YearFilings
20181
20212
20221
20234
20242
20253

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon